Cormorant Asset Management, LP - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$57,403,500
+38.0%
3,850,000
+1.3%
3.35%
+43.6%
Q2 2023$41,610,000
+375204.4%
3,800,000
+198.9%
2.33%
+219.3%
Q1 2023$11,087
-99.7%
1,271,429
+154.3%
0.73%
+2.5%
Q3 2017$4,030,000500,0000.71%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,653,495$10,367,4148.97%
Versant Venture Management, LLC 543,753$3,409,3307.06%
TCG Crossover Management, LLC 5,905,400$37,026,8586.54%
COMMODORE CAPITAL LP 5,738,500$35,9805.42%
Foresite Capital Management IV, LLC 1,787,094$11,205,0794.79%
Saturn V Capital Management LP 1,611,778$5,718,4324.74%
ACUTA CAPITAL PARTNERS, LLC 1,015,000$6,364,0503.92%
Altium Capital Management LP 1,025,000$6,426,7503.27%
Affinity Asset Advisors, LLC 1,143,531$7,169,9392.81%
GREAT POINT PARTNERS LLC 1,550,000$9,718,5001.90%
View complete list of CYMABAY THERAPEUTICS INC shareholders